Your Money with Michelle Martin

Michelle Martin gets help from Cheng Chye Hsern, Head of Investment, Providend to make sense of the Nasdaq's recent market correction, the Feds' increasingly hawkish stance to raise interest rate hikes and the surprise off-cycle tightening move by the Monetary Authority of Singapore. See omnystudio.com/listener for privacy information.

China's government has injected state funds to help prop up stocks that have been in a bear market, as it has done before. Which stocks have seen a rally since then? Is it a good time to buy into Winter Olympics fever? Michelle Martin says get ready your stomach and risk appetite. See omnystudio.com/listener for privacy information.

Michelle Martin and Ryan Huang's midweek Market View starts with a look at the latest in crypto hacking and a report on Singapore's status a a fintech hub. The agenda continues with a discussion on Carousell's reported plans to acquire 99.co, a billion-dollar makeover for Marina Bay Sands, a shake-up at Peloton and a check-in on Pfizer, BP, UOB and ComfortDelGro.See omnystudio.com/listener for privacy information.

On this episode of Money & Me, Michelle Martin gets James Quinn, Managing Partner, Q9 Capital to give his take on the themes on the cryptocurrency market in 2022, following a volatile start to the year, how inflation and geo-politics could impact the market and what is shaping up in terms of institutional inflows and NFT’s’ popularity in Asia.See omnystudio.com/listener for privacy information.

Will Meta comply with Europe's regulations, or will there be no more Facebook in Europe? Is Softbank the mysterious shareholder exiting Alibaba? Michelle Martin and Ryan Huang discuss these at length, plus Amazon raising wages, the impact of tensions over Ukraine, rollback of Trump-era tariffs in Japan, two US budget carriers merge and what to make of the MAS' latest move on DBS. See omnystudio.com/listener for privacy information.

Pfizer is due to release its earnings in the US tonight and the stage is set for what's been dubbed "record-shattering revenues", and analysts believe two new products will bring sales beyond the US$1 billion mark. But can the pharmaceutical giant sustain these gains  in the medium to long term? Michelle Martin finds out. See omnystudio.com/listener for privacy information.

Almost a third of Singaporeans do not have a financial plan and a similar number are not comfortable with their current amount of savings. Michelle Martin talks to Elson Goh, Head of Asia Portfolio Management, St. James’s Place Singapore to find out why, and what investors can do about their financial health.See omnystudio.com/listener for privacy information.

Yum Brands -- KFC's parent company -- has been busying itself with expansions and lucrative partnerships. Can investors expect a strong earnings report when it's released this Wednesday? Michelle Martin finds two analysts who are overweight on the Kentucky-based company and why. See omnystudio.com/listener for privacy information.

Michelle Martin and Ryan Huang take a look at suitors that are looking to snap up pandemic darling Peloton, including Nike, Apple, Amazon and even Disney. Then, they discuss the criticism behind the unexpected pivot by backpacker hostel operator Sinjia Land to sorghum producer Binex. Plus, an overview of this week's outlook from a host of major companies. See omnystudio.com/listener for privacy information.

Backed by Amazon and Ford Motors, Rivian Automotive's share price has tanked amid the latest rout in tech stocks. So is it a good time to buy the dip? Michelle Martin finds there could be good news on the horizon. See omnystudio.com/listener for privacy information.